Standard Operational Procedures for Low Sexual Desire in Men

Journal of Sexual Medicine

Volumn 10, Issue 1, 2013, Pages 94-107

  Rubio Aurioles, Eusebio ^a   Bivalacqua, Trinity J ^b  

^a A C AMSSAC Sexual Medicine Research   (Mexico)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Hypoactive Sexual Desire Disorder; Low Sexual Desire; Sexual Interest

Indexed keywords

AMFEBUTAMONE; APOMORPHINE; CIMETIDINE; FLIBANSERIN; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROLACTIN; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; HUMAN; HUMAN RELATION; HYPOACTIVE SEXUAL DESIRE DISORDER; LOW SEXUAL DESIRE; MALE SEXUAL DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RISK FACTOR; SCREENING; SEXUAL BEHAVIOR;

EID: 84872873762     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02778.x     Document Type: Article

References (74)

1. Fugl-Meyer KS, Lewis RW, Corona G, Hayes RD, Laumann EO, Moreira ED, Rellini AH, Segraves T. Definitions, classification, and epidemiology of sexual dysfunction. In: Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I, eds. Sexual medicine sexual dysfunctions in men and women: 3rd International Consultation on Sexual Medicine. Paris: Health Publication Ltd; 2010:41-117.
2. Rubio-Aurioles E. Hypoactive sexual desire on men. In: Porst H, Buvat J; The Standards Committee of the International Society for Sexual Medicine, eds. Standard practice in sexual medicine. Malden, MA: Blackwell Publishing; 2006:149-57.
3. International Society for Sexual Medicine. The Standards Committee of the International Society for Sexual Medicine. Meeting of the Standards Committee, June 23-27, 2010 Nuremberg: Germany.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, Text revision edition. Washington, DC: American Psychiatric Association; 2000.
5. Pridal CG, Lopiccolo J. Multielement treatment of desire disorders: Integration of cognitive, behavioral, and sytemic therapy. In: Leiblum SR, Rosen RC, eds. Principles and practice of sex therapy. 3rd edition. New York: The Guilford Press; 2000.
6. Meuleman EJ, Van Lankvled J. Hypoactive sexual desire disorder: An underestimated condition in men. BJU Int 2005;95:201-96.
7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
8. Clogg CC. Latent class models. In: Arminger G, Clogg CC, Sobel ME, eds. Handbook of statistical modeling for the social and behavioral sciences. New York, NY: Plenum Press; 1995:311-59.
9. McCutcheon AL. Latent class analysis. Newbury Park, CA: Sage Publications; 1987.
10. Laumann EO, Nicolosi A, Glasser DB, Paik A, Ginge C, Moreira E, Wang T. Sexual problems among women and men aged 40-80y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57.
11. Levine SB. The nature of sexual desire: A clinician's perspective. Arch Sex Behav 2003;32:279-85.
12. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-30.
13. Davidson JM, Kwan M, Greenleaf WJ. Hormonal replacement and sexuality. Clin Endocrinol Metab 1982;11:599-623.
14. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: A combined laboratory/self-report study on hypogonadal men. Clin Endocrinol Metab 1983;57:557-62.
15. Skakkeoaek NE, Bancroft J, Davidson DW, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonodal men: A double-blind controlled study. Clin Endocrinol 1981;14:49-61.
16. Halpern CT, Udry JR, Campbell B, Suchindran C, Mason GA. Testosterone and religiosity as predictors of sexual attitudes and activity among adolescent males: A biosocial model. J Biosoc Sci 1994;26:217-34.
17. Udry JR, Billy JO, Morris NM, Groff TR, Raj MH. Serum androgenic hormones motivate sexual behavior in adolescent boys. Fertil Steril 1985;43:90-4.
18. Schiavi RC, White D. Androgen and male sexual function: A review of human studies. J Sex Marital Ther 1976;2:214-28.
19. Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behavior by drugs, I: Behavioral changes following oestrogens and anti-androgens. Br J Psychiatry 1974;125:310-5.
20. Heller CG, Laidlaw WM, Harvey HT, Nelson WO. Effects of progestational compounds on the reproductive processes of the human male. Ann N Y Acad Sci 1958;71:649-65.
21. Money J. Use of an androgen-depleting hormone in the treatment of male sex offenders. J Sex Res 1970;6:165-72.
22. Bancroft J. Hormones and human sexual behavior. J Sex Martial Ther 1984;10:3-21.
23. Bancroft J, O'Carroll R, McNeilly A, Shaw R. The effects of bromocriptine on the sexual behavior of a hyperprolactinaemic man: A controlled case study. Br J Psychiatry 1984;21:131-7.
24. Buckman MT, Kellner R. Reduction of distress in hyperprolactinemia with bromocriptine. Am J Psychiatry 1984;6:351-8.
25. Dornan WA, Malsbury CW. Neuropeptides and male sexual behavior. Neurosci Biobehav Rev 1989;13:1-15.
26. Muller P, Musch K, Wolf AS. Prolactin: Variables of personality and sexual behavior. In: Zichella L, Pancheri P, eds. Psychoneuroendocrinology in reproduction. Amsterdam, the Netherlands: Elsevier/North Holland Biomedical Press; 1979:357-72.
27. Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing's syndrome: Relationship to hormone levels. Psychosom Med 1981;43:3-18.
28. Cutler WB, Friedmann E, McCoy NL. Pheromonal influences on sociosexual behavior in men. Arch Sex Behav 1998;27:1-13.
29. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Buosono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De La Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-93.
30. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-83.
31. White JM, Rumbold GR. Behavioral effects of histamine and its antagonists: A review. Psychopharmacology 1988;95:1-14.
32. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Kim YC, Tan HM, Torrres LO. Endocrine aspects of men sexual dysfunction. In: Lue TF, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F, eds. Sexual medicine: Sexual dysfunction in men and women: 2nd International Consultation on Sexual Dysfunctions. Paris: Health Publications; 2004:345-82.
33. Zitzmann M, Faber S, Nieschlang E. Association of specific symptoms and metabolic risk with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43.
34. Dei M, Verni A, Bigozzi L, Bruni V. Sex steroids and libido. Eur J Contracept Reprod Health Care 1997;2:253-8.
35. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005;90:6472-9.
36. Corona G, Mannucci E, Petrone L, Giommi R, Mansani R, Fei L, Forti G, Maggi M. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res 2004;16:275-81.
37. Aubin S, Berger RE, Herman JR, Ciol MA. The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III. J Sex Med 2008;5:657-67.
38. DeRogatis L, Rosen R, Goldstein I, Werneburg B, Kempthorne-Rawson J, Sand M. Characterization of Hypoactive Sexual Desire Disorder (HSDD) in men. Abstract to be presented in the 14th Congress of the European Society for Sexual Medicine. December 1-4, 2011, Milan, Italy.
39. Stoléru S, Redouté J, Costes N, Lavenne F, Le Barsb D, Dechaud H, Forest MG, Pugeat M, Cinotti L, Pujol JF. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res 2003;124:67-86.
40. Carvalho J, Nobre P. Biopsychosocial determinants of men's sexual desire: Testing an integrative model. J Sex Med 2011;8:754-63.
41. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. 2011. Available at: http://www.cebm.net/index.aspx?o=5653 (accessed September 15, 2011).
42. Levine SB. Hypoactive Sexual Desire Disorder in Men: Basic types, causes, and treatment. Psychiatric Times 2010:40-3.
43. LoPiccolo J, Friedman J. Broad spectrum treatment of low sexual desire: Integration of cognitive, behavioral and systemic therapy. In: Lieblum S, Rosen R, eds. Sexual desire disorders. New York: The Guilford Press; 1988:107-44.
44. Schiavi RC. Interview, psychometric and psycho physiologic strategies to assess sexual disorders. J Clin Psychiatry Monogr 1992;10:10-9.
45. Kennedy SH, Dickens SE, Eisfeld BS, Bagbya RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999;56:201-8.
46. Whooley M, Avins A, Miranda J, Browner W. Case finding instruments for depression: Two questions are as good as many. J Gen Intern Med 1997;12:439-45.
47. Begin C, Sabourin M, Bovin E. Frénetté. Paradis. The Couple-Part 1-Couple distress factors associated with evaluating the spousal relationship. In: Quebec Longitudinal Study of Child Development (QLSCD 1998-2002) From Birth to 29 Months. Québec, Institut de la statistique du Québec, Vol 2 No. 11. 2002. Available at: http://www.bdso.gouv.qc.ca/docs-ken/multimedia/BabyV2No11.pdf (accessed July 26, 2011).
48. Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: Results of a meta-analysis. Clin Endocrinol 2005;63:381-94.
49. Krüger THC, Haake P, Haverkamp J, Krämer M, Exton MS, Saller B, Leygraf N, Hartmann U, Schedlowski M. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol 2003;179:357-65.
50. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, Petrone L, Forti G, Maggi M. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med 2008;5(2 suppl):94-145.
51. American Association of Clinical Endocrinologist. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: A couple's problem-2003 update. Endocr Pract 2003;9:77-95.
52. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N; the Testosterone Gel Study Group. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000;85:839-53.
53. Allan CA, Forbes EA, Strauss BJG, McLachlan R. Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. Int J Impot Res 2008;20:396-401.
54. Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, Sanfilippo J, Webster J, Zacur H. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 1999;44(suppl):1075-84.
55. Schlechte JA. Update in Pituitary 2010. J Clin Endocrinol Metab 2011;96:1-8. doi: 10.1210/jc.2010-2410.
56. Clayton A, Keller A, McGarvey E. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006;91:27-32.
57. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4:917-29.
58. Cuijpers P, van Straten A, Hollon SD, Andersson G. The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: A meta-analysis. Acta Psychiatr Scand 2010;121:415-23.
59. Corretti G, Baldi I. The relationship between anxiety disorders and sexual dysfunction. Psychiatr Times 2007;24:1-7. Available at: http://www.psychiatrictimes.com/display/article/10168/54881 (accessed September 25, 2011).
60. Klann N, Hahlweg K, Baucom DH, Kroeger C. The effectiveness of couple therapy in Germany: A replication study. J Marital Fam Ther 2011;37:200-8.
61. Gehring D. Couple therapy for low sexual desire: A systemic approach. J Sex Marital Ther 2003;29:25-38.
62. Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am 2001;28:269-78.
63. Ferris RM, Cooper BR, Maxwell RA. studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry 1983;44:74-8.
64. Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001;27:303-16.
65. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004;24:339-42.
66. Crenshaw TL, Goldberg JP, Stern WC. Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther 1987;13:239-52.
67. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011;8:15-27.
68. Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): Results from a randomized withdrawal trial. J Sex Med 2011;8:3160-70.
69. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317-30.
70. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357-64.
71. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women. Obstet Gynecol 2008;112:970-8.
72. Clayton AH, Goldfischer ER, Goldstein I, DeRogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalized acquired female Hypoactive Sexual Desire Disorder (HSDD). J Sex Med 2009;6:730-8.
73. Masters WH, Johnson V. Human sexual inadequacy. Boston: Little Brown; 1970.
74. Kaplan HS. The sexual desire disorders. Dysfunctional regulation of sexual motivation. Levittown, PA: Brunner/Mazel; 1995.